Cargando…

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles

Despite recent advances in both surgery and chemoradiotherapy, mortality rates for advanced cancer remain high. There is a pressing need for novel therapeutic strategies; one option is systemic oncolytic viral therapy. Intravenous administration affords the opportunity to treat both the primary tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferguson, Mark S., Lemoine, Nicholas R., Wang, Yaohe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287020/ https://www.ncbi.nlm.nih.gov/pubmed/22400027 http://dx.doi.org/10.1155/2012/805629

Ejemplares similares

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)

The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles
por: Tang, Guijin, et al.
Publicado: (2023)

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
por: Yuan, Ming, et al.
Publicado: (2016)

Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
por: Howells, Anwen, et al.
Publicado: (2017)

Update on oncolytic viral therapy – targeting angiogenesis
por: Tysome, James R, et al.
Publicado: (2013)

Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
por: Marelli, Giulia, et al.
Publicado: (2018)

Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
por: Aslan, Cynthia, et al.
Publicado: (2021)

Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
por: Ferguson, Mark S., et al.
Publicado: (2020)

CAR-T cell therapy in myeloma: hopes and hurdles
por: Harousseau, Jean Luc
Publicado: (2023)

Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis
por: Neuber, Sebastian, et al.
Publicado: (2021)

Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation
por: Burnouf, Thierry, et al.
Publicado: (2019)

Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2020)

Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022)

Towards Interoperable Reporting Standards for Omics Data: Hopes and Hurdles
por: Sansone, Susanna-Assunta, et al.
Publicado: (2009)

An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
por: Sun, Yijie, et al.
Publicado: (2022)

Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2021)

Oncolytic Viruses in Head and Neck Cancer: A New Ray of Hope in the Management Protocol
por: Shilpa, PS, et al.
Publicado: (2014)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2021)

Hyperbaric Oxygen Therapy for Diabetic Foot Wounds: Has hope hurdled hype?
por: Lipsky, Benjamin A., et al.
Publicado: (2010)

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
por: Ferrari, Samuele, et al.
Publicado: (2021)

Systemic treatment of penile squamous cell carcinoma—hurdles and hopes of preclinical models and clinical regimens: a narrative review
por: Thomas, Anita, et al.
Publicado: (2021)

Small interfering RNA for cancer treatment: overcoming hurdles in delivery
por: Charbe, Nitin Bharat, et al.
Publicado: (2020)

Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
por: Garcia-Moure, Marc, et al.
Publicado: (2016)

Immune cells: more than simple carriers for systemic delivery of oncolytic viruses
por: Eisenstein, Samuel, et al.
Publicado: (2014)

Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus
por: Kirn, David H, et al.
Publicado: (2007)

A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020)

A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
por: Ahmed, Jahangir, et al.
Publicado: (2020)

Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
por: Ghaleh, Hadi Esmaeili Gouvarchin, et al.
Publicado: (2023)

Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy
por: Ban, Weiyue, et al.
Publicado: (2022)

Hurdles to Cardioprotection in the Critically Ill
por: See Hoe, Louise E, et al.
Publicado: (2019)

Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
por: Stepanenko, Aleksei A., et al.
Publicado: (2018)

Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours
por: Hiley, Crispin T, et al.
Publicado: (2009)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer
por: Kober, Christina, et al.
Publicado: (2015)

Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
por: Hamada, Masakazu, et al.
Publicado: (2020)

Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors
por: Yoon, A-Rum, et al.
Publicado: (2022)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Clinical landscape of oncolytic virus research in 2020
por: Macedo, Nicholas, et al.
Publicado: (2020)

Developing Oncolytic Viruses for the Treatment of Cervical Cancer
por: Kalafati, Eleni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k0l172j14vg38b0faerhll39l2